These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 620459)

  • 1. Myotonic dystrophy: studies on the lipid composition and metabolism of erythrocytes and skin fibroblasts.
    Thomas NS; Harper PS
    Clin Chim Acta; 1978 Feb; 83(1-2):13-23. PubMed ID: 620459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased plasmalogen ratios in cultured skin fibroblasts from myotonic dystrophy.
    Sakai T; Antoku Y
    Muscle Nerve; 1987 Sep; 10(7):626-8. PubMed ID: 3657848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding activity and autophosphorylation of the insulin receptor from patients with myotonic dystrophy.
    Kakehi T; Kuzuya H; Kosaki A; Yamada K; Yoshimasa Y; Okamoto M; Nishimura H; Nishitani H; Saida K; Kuno S
    J Lab Clin Med; 1990 Jun; 115(6):688-95. PubMed ID: 2195130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stoichiometry of sodium and potassium transport in erythrocytes from patients with myotonic muscular dystrophy.
    Hull KL; Roses AD
    J Physiol; 1976 Jan; 254(1):169-81. PubMed ID: 129563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased binding of insulin to erythrocytes in myotonic dystrophy.
    Sakai K; Takase S; Kumagai K; Shimizu F
    Tohoku J Exp Med; 1985 Jun; 146(2):193-9. PubMed ID: 3895577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spin-label studies of erythrocytes in myotonic dystrophy: no increase in membrane fluidity.
    Gaffney BJ; Drachman DB; Lin DC; Tennekoon G
    Neurology; 1980 Mar; 30(3):272-6. PubMed ID: 7189026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The sialic acid and galactose concentrations in erythrocyte membranes in patients with myotonic dystrophy, limb-girdle and facioscapulohumeral dystrophy.
    Stibler H; Sydow O
    J Neurol Sci; 1983 Jun; 59(3):389-99. PubMed ID: 6875606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of cholesterol and lipid synthesis by insulin in familial hypercholesterolemic fibroblasts.
    Amorosa LF; Khachadurian AK; Islam MA; Yamin TT
    Metabolism; 1986 May; 35(5):411-4. PubMed ID: 3517555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The fatty acid composition of various lipid fractions isolated from erythrocytes and blood plasma of patients with Duchenne and congenital myotonic muscular dystrophy.
    Ruitenbeek W
    Clin Chim Acta; 1978 Oct; 89(1):99-110. PubMed ID: 709871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro studies of fibroblasts in myotonic dystrophy (author's transl)].
    Nappi G; Kauchtschischvili G; Poloni M; Castello A; Lo Curto F
    Riv Patol Nerv Ment; 1974 Oct; 95(5):632-6. PubMed ID: 4143399
    [No Abstract]   [Full Text] [Related]  

  • 11. Myotonic dystrophy: a disease caused by functional zinc deficiency due to an abnormal zinc-binding ligand?
    Horrobin DF; Morgan RO
    Med Hypotheses; 1980 Apr; 6(4):375-84. PubMed ID: 6995820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration and fatty acid composition of serum lipids in myotonia dystrophica. With special reference to pathogenesis.
    Wakamatsu H; Nakamura H; Ito K; Anazawa W; Okajima S; Shigeno K; Goto Y
    Horm Metab Res; 1972 Nov; 4(6):458-62. PubMed ID: 4655500
    [No Abstract]   [Full Text] [Related]  

  • 13. Phenytoin and membrane fluidity in myotonic dystrophy.
    Roses AD; Butterfield A; Appel SH; Chestnut DB
    Arch Neurol; 1975 Aug; 32(8):535-8. PubMed ID: 168843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormalities of erythrocyte membranes in myotonic muscular dystrophy manifested in lipid vesicles.
    Nagano Y; Roses AD
    Neurology; 1980 Sep; 30(9):989-91. PubMed ID: 7191543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patients with myotonic dystrophy, a possible segmental progeroid syndrome, and Duchenne muscular dystrophy have fibroblasts with normal limits for in vitro lifespan and growth characteristics.
    Wertz RL; Hartwig GB; Frost AP; Brophy JJ; Atwater SK; Roses AD
    J Cell Physiol; 1981 May; 107(2):255-60. PubMed ID: 7251683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myotonic dystrophy: investigation of the proposed defect in guanidoacetic acid synthesis.
    Bolton CE; Emery AE
    J Neurol Neurosurg Psychiatry; 1972 Dec; 35(6):801-3. PubMed ID: 4647851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myotonic muscular dystrophy: defective phospholipid metabolism in the erythrocyte plasma membrane.
    Grey JE; Gitelman HJ; Roses AD
    J Clin Invest; 1980 Jun; 65(6):1478-82. PubMed ID: 7410551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of triiodothyronine, hydrocortisone and insulin on lipid synthesis by cultured fibroblasts preincubated in a serum-free medium.
    Amorosa LF; Khachadurian AK; Harris JN; Schneider SH; Fung CH
    Biochim Biophys Acta; 1984 Feb; 792(2):192-8. PubMed ID: 6365171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative studies on human skin fibroblasts: life span and lipid metabolism in medium containing fetal bovine or human serum.
    Cooper JT; Goldstein S
    In Vitro; 1977 Aug; 13(8):473-6. PubMed ID: 903170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Spectrin extractabilities from erythrocyte membranes in patients with myotonic dystrophy].
    Li YS
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Dec; 24(6):343-5, 383. PubMed ID: 1800059
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.